• Publications
  • Influence
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.
This paper is the second in a series of three publications relating to the European evidence-based consensus on the diagnosis and management of Crohn's disease and concerns the management of activeExpand
  • 1,441
  • 63
  • PDF
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
### 5.1 General When deciding the appropriate treatment strategy for active ulcerative colitis one should consider the activity, distribution (proctitis, left-sided, extensive1), and pattern ofExpand
  • 1,116
  • 54
  • PDF
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1 Diagnosis and Medical Management
This paper is the first in a series of two publications relating to the European Crohn’s and Colitis Organisation [ECCO] evidence-based consensus on the diagnosis and management of Crohn’s diseaseExpand
  • 866
  • 43
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Principal changes with respect to the 2004 ECCO guidelines Ileocolonoscopy is recommended within the first year after surgery where treatment decisions may be affected (Statement 8C). ThiopurinesExpand
  • 812
  • 38
  • PDF
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
### 1.1 Introduction Ulcerative colitis is a lifelong disease arising from an interaction between genetic and environmental factors, observed predominantly in the developed countries of the world.Expand
  • 675
  • 35
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
### 8.1 General Proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the procedure of choice for most patients with ulcerative colitis (UC) requiring colectomy.1 Pouchitis is a non-specificExpand
  • 386
  • 16
  • PDF
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
BACKGROUND & AIMS Dietary restriction of fermentable carbohydrates (a low FODMAP diet) has been reported to reduce symptoms in some patients with irritable bowel syndrome (IBS). We performed aExpand
  • 165
  • 13
  • PDF
Health‐economic analysis: cost‐effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease – modelling outcomes in active luminal and fistulizing disease in adults
Background  Infliximab has been shown to be efficacious in moderate‐to‐severe Crohn’s disease (CD).
  • 68
  • 8
Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease
Background and aims: The intestinal microbiota play a pivotal role in the inflammation associated with Crohn’s disease through their interaction with the mucosal immune system. Some bifidobacteriaExpand
  • 276
  • 7
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease
Introduction The commensal intestinal microbiota drive the inflammation associated with Crohn's disease. However, bacteria such as bifidobacteria and Faecalibacterium prausnitzii appear to beExpand
  • 225
  • 7
...
1
2
3
4
5
...